Evidence map›Paper›PMID 42766224›Full record

ArticleWorld journal of microbiology & biotechnology2026

Development of a lactose-complemented antibiotic-free host-vector platform for stable enzyme expression in Limosilactobacillus fermentum 217 - 82.

Ruize Xu, Junlin Li, Fangyu Guo, Weiyan Wang, Chen Yang, Zhenshang Xu, Ting Wang

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruize Xu *State Key Laboratory of Green Papermaking and Resource Recycling, Qilu University of Technology, Shandong Academy of Science, Jinan, 250353, P. R. China.
Junlin Li *State Key Laboratory of Green Papermaking and Resource Recycling, Qilu University of Technology, Shandong Academy of Science, Jinan, 250353, P. R. China.
Fangyu GuoState Key Laboratory of Green Papermaking and Resource Recycling, Qilu University of Technology, Shandong Academy of Science, Jinan, 250353, P. R. China.
Weiyan WangState Key Laboratory of Green Papermaking and Resource Recycling, Qilu University of Technology, Shandong Academy of Science, Jinan, 250353, P. R. China.
Chen YangState Key Laboratory of Green Papermaking and Resource Recycling, Qilu University of Technology, Shandong Academy of Science, Jinan, 250353, P. R. China.
Zhenshang XuState Key Laboratory of Green Papermaking and Resource Recycling, Qilu University of Technology, Shandong Academy of Science, Jinan, 250353, P. R. China. xuzhenshang@126.com.ORCID https://orcid.org/0000-0001-9570-5772
Ting WangState Key Laboratory of Green Papermaking and Resource Recycling, Qilu University of Technology, Shandong Academy of Science, Jinan, 250353, P. R. China. tingwang_97@hotmail.com.

Funding

Key innovation Project of Qilu University of Technology (Shandong Academy of Sciences) 2024ZDZX03Key Innovation Project of Qilu University of Technology (Shandong Academy of Sciences) 2025ZDZX14Major Scientific Research Project for the Construction of State Key Lab 2025ZDGZ02Natural Science Foundation of Shandong Province ZR2022MC059Project for the Innovation Capacity Enhancement Project of Technology-based Small and Medium-sized Enterprises in Shandong Province 2023TSGC0765
6 · The paper itself

Abstract

Food-grade microbial bioprocessing requires genetically stable and antibiotic-free host-vector systems that are compatible with food-related applications. However, the use of Limosilactobacillus fermentum as a biomanufacturing chassis is limited by inefficient DNA delivery and the lack of strain-adapted food-grade selection strategies. In this study, a proof-of-concept, lactose-complemented antibiotic-free host-vector framework was established in L. fermentum 217 - 82. An efficient electrotransformation protocol was first established as an enabling step for host engineering, yielding a transformation efficiency of 7.50 × 10⁵ CFU/µg DNA. The genes lacM and lacLM were individually targeted to validate their involvement in lactose utilization, and subsequent gene inactivation experiments confirmed their utility as effective markers for metabolic complementation. Antibiotic-free shuttle vectors were constructed by combining lacZα-assisted plasmid screening in E. coli with host-specific lacM/lacLM-mediated lactose complementation in L. fermentum. The resulting recombinant strains maintained plasmid stability during serial passage and supported functional heterologous expression of cis-proline 4-hydroxylase. Functional validation using cis-proline 4-hydroxylase confirmed that the platform supported whole-cell L-proline-to-hydroxyproline bioconversion, with hydroxyproline production reaching 147.62 µg/mL. These findings demonstrate the feasibility of integrating lactose-dependent selection, stable antibiotic-free plasmid maintenance, functional heterologous enzyme expression, and whole-cell bioconversion within a strain-adapted host-vector framework in L. fermentum 217 - 82. Although broader applicability remains to be validated using additional heterologous proteins and process conditions, the established framework provides a methodological basis for the future development of more generally applicable antibiotic-free expression platforms in L. fermentum.

Indexed as

Genetic VectorsLactoseLimosilactobacillus fermentumAnti-Bacterial AgentsEscherichia coliGene ExpressionPlasmidsTransformation, BacterialAnti-Bacterial AgentsLactoseAntibiotic-free selectionFood-grade bioprocessingLactic acid bacteriaLactose complementationLimosilactobacillus fermentumWhole-cell bioconversion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.